russjcardiolРоссийский кардиологический журналRussian Journal of Cardiology1560-40712618-7620«SILICEA-POLIGRAF» LLC10.15829/1560-4071-2016-4-7-13russjcardiol-705Research ArticleПЕРЕДОВАЯ СТАТЬЯКОНЦЕПЦИЯ НОВЫХ НАЦИОНАЛЬНЫХ КЛИНИЧЕСКИХ РЕКОМЕНДАЦИЙ ПО ОЖИРЕНИЮTHE CONCEPT OF NOVEL NATIONAL CLINICAL GUIDELINES ON OBESITYШляхтоЕ. В.ShlyakhtoE. V.

академик РАН, профессор, д.м.н., директор,

Санкт-Петербург

Saint-Petersburg

obesityrecom@rambler.ruНедогодаС. В.NedogodaS. V.

профессор, д.м.н., заведующий кафедрой терапии и эндокринологии,

Волгоград

Volgograd

obesityrecom@rambler.ruКонрадиА. О.KonradiA. O.

профессор, д.м.н., заместитель директора по научной работе и заведующая научно-исследовательским отделом артериальной гипертензии,

Санкт-Петербург

Saint-Petersburg

obesityrecom@rambler.ruБарановаЕ. И.BaranovaE. I.

д.м.н., профессор кафедры факультетской терапии с курсом эндокринологии,

Санкт-Петербург

Saint-Petersburg

obesityrecom@rambler.ruФоминВ. В.FominV. V.

д.м.н., профессор кафедры внутренних, профессиональных болезней и пульмонологии медико-профилактического факультета,

Москва

Moscow

obesityrecom@rambler.ruВерткинА. Л.VertkinA. L.

профессор, д.м.н., заведующий кафедрой терапии, клинической фармакологии и скорой медицинской помощи,

Москва

Moscow

obesityrecom@rambler.ruЧумаковаГ. А.ChumakovaG. A.

профессор, д.м.н., профессор кафедры госпитальной и поликлинической терапии с курсами профессиональных болезней и эндокринологии,

Барнаул

Barnaul

obesityrecom@rambler.ruФГБУ Северо-Западный федеральный медицинский исследовательский центр им. В. А. Алмазова Минздрава РоссииРоссияFederal Almazov North-West Medical Research Centre of the Ministry of HealthRussian FederationГБОУ ВПО Волгоградский государственный медицинский университет Минздрава РоссииРоссияVolgograd State Medical UniversityRussian FederationГБОУ ВПО Санкт-Петербургский государственный медицинский университет имени акад. И. П. Павлова Минздрава РоссииРоссияI.P. Pavlov Saint-Petersburg State Medical University of the Ministry of HealthRussian FederationГБОУ ВПО Первый МГМУ им. И. М. Сеченова Минздрава РоссииРоссияI.M. Sechenov First Moscow State Medical University of the Ministry of HealthRussian FederationГБОУ ВПО МГМСУ им. А. И. Евдокимова Минздрава РоссииРоссияA.I. Evdokimov Moscow State University of Medicine and Dentistry (MSUMD)Russian FederationГБОУ ВПО Алтайский государственный медицинский университет Минздрава РоссииРоссияAltai State Medical University of the Ministry of HealthRussian Federation20162804201604РОССИЙСКИЙ КАРДИОЛОГИЧЕСКИЙ ЖУРНАЛ713Copyright © Шляхто Е.В., Недогода С.В., Конради А.О., Баранова Е.И., Фомин В.В., Верткин А.Л., Чумакова Г.А., 20162016Шляхто Е.В., Недогода С.В., Конради А.О., Баранова Е.И., Фомин В.В., Верткин А.Л., Чумакова Г.А.Shlyakhto E.V., Nedogoda S.V., Konradi A.O., Baranova E.I., Fomin V.V., Vertkin A.L., Chumakova G.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://russjcardiol.elpub.ru/jour/article/view/705Цель

Цель. Предложить для обсуждения концепцию новых Национальных клинических рекомендаций по ожирению.

Материал и методы

Материал и методы. На основе анализа наиболее важных существующих документов и рекомендаций по проблеме ожирения (EASO guidelines (2008, 2014), NICE Guidelines (2012, 2014), AHA/ACC/TOS Guidelines (2013), AACE Advanced Framework (2014), ASBP Algorithm (2014), The Endocrine Society Guidelines Pharmacologic Management of Obesity (2015), Physical Activity Guidelines for Americans (2008), ACC/AHA Lifestyle Guidelines (2013), Dietary Guidelines for Americans (2015) разработана концепция Национальных рекомендаций по профилактике, диагностике и лечению ожирения.

Результаты

Результаты. Разработана новая отечественная, целостная, оригинальная, но вместе с тем гармонизированная с существующими зарубежными рекомендациями, концепция для последующей разработки междисциплинарных клинических рекомендаций по ожирению.

Заключение

Заключение. Представлены для обсуждения медицинским сообществом основные положения будущих Национальных рекомендаций по профилактике, диагностике и лечению ожирения.

 

 

Aim

Aim. Proposal for discussion of the new concept of National Clinical Guidelines on obesity.

Material and methods

Material and methods. Based on the analysis of the main current documents and guidelines on obesity (EASO guidelines (2008, 2014), NICE Guidelines (2012, 2014), AHA/ACC/TOS Guidelines (2013), AACE Advanced Framework (2014), ASBP Algorithm (2014), The Endocrine Society Guidelines Pharmacologic Management of Obesity (2015), Physical Activity Guidelines for Americans (2008), ACC/AHA Lifestyle Guidelines (2013), Dietary Guidelines for Americans (2015) we developed new concept of the Guidelines on Prevention, Diagnostics and Management of Obesity.

Results

Results. A new local, original and solid, but also harmonized with current international guidelines, concept for further elaboration of interdisciplinary clinical guidelines on obesity.

Conclusion

Conclusion. The main positions are proposed for discussion of the future National guidelines on obesity.

ожирениеклассификациякритерии диагностикиobesityclassificationdiagnostic criteriaReferencesWorld health statistics 2013 (electronic resource). Russian (Мировая статистика здравоохранения, 2013 (электронный ресурс, http://apps.who.int/iris/bitstream/10665/81965/7/9789244564585_rus.pdf?ua=1).World health statistics 2013 (electronic resource). Russian (Мировая статистика здравоохранения, 2013 (электронный ресурс, http://apps.who.int/iris/bitstream/10665/81965/7/9789244564585_rus.pdf?ua=1).Bondarenko IZ, et al. Treatment of morbid obesity in adults. National clinical guidelines. Obesity and metabolism 2011; 3. Russian (Бондаренко И. З. и др. Лечение морбидного ожирения у взрослых. Национальные клинические рекомендации. Ожирение и метаболизм 2011; 3).Bondarenko IZ, et al. Treatment of morbid obesity in adults. National clinical guidelines. Obesity and metabolism 2011; 3. Russian (Бондаренко И. З. и др. Лечение морбидного ожирения у взрослых. Национальные клинические рекомендации. Ожирение и метаболизм 2011; 3).Clinical practice guidelines for bariatric and metabolic surgery. Russian society of surgeons, the Society of bariatric surgeons. 2014. Russian (Клинические рекомендации по бариатрической и метаболической хирургии. Российское общество хирургов, Общество бариатрических хирургов. 2014).Clinical practice guidelines for bariatric and metabolic surgery. Russian society of surgeons, the Society of bariatric surgeons. 2014. Russian (Клинические рекомендации по бариатрической и метаболической хирургии. Российское общество хирургов, Общество бариатрических хирургов. 2014).Fried M, et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 2014; 24; 1: 42-55.Fried M, et al. International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC); European Association for the Study of Obesity (EASO); European Association for the Study of Obesity Obesity Management Task Force (EASO OMTF). Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 2014; 24; 1: 42-55.Stegenga H, et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ 2014; 349: g6608.Stegenga H, et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. BMJ 2014; 349: g6608.Yumuk V, et al. An EASO position statement on multidisciplinary obesity management in adults. Obesity facts 2014; 7, 2; 96-101.Yumuk V, et al. An EASO position statement on multidisciplinary obesity management in adults. Obesity facts 2014; 7, 2; 96-101.Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American College of Cardiology 2014; 63, 25_PA: 2985-3023.Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American College of Cardiology 2014; 63, 25_PA: 2985-3023.Garvey W, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease. Endocrine Practice 2014.Garvey W, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease. Endocrine Practice 2014.Seger JC, et al. American Society of Bariatric Physicians Obesity Algorithm: Adult Adiposity Evaluation and Treatment 2013.Seger JC, et al. American Society of Bariatric Physicians Obesity Algorithm: Adult Adiposity Evaluation and Treatment 2013.Seger JC, et al. Obesity algorithm, presented by the American Society of Bariatric Physicians 2014.Seger JC, et al. Obesity algorithm, presented by the American Society of Bariatric Physicians 2014.Apovian CM, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2015.Apovian CM, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2015.Physical Activity Guidelines Advisory Committee et al. Physical activity guidelines for Americans. Washington, DC: US Department of Health and Human Services 2008: 15-34.Physical Activity Guidelines Advisory Committee et al. Physical activity guidelines for Americans. Washington, DC: US Department of Health and Human Services 2008: 15-34.Jakicic JM, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk 2013.Jakicic JM, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk 2013.Rahavi E, et al. Updating the Dietary Guidelines for Americans: Status and Looking Ahead. Journal of the Academy of Nutrition and Dietetics 2015; 115, 2: 180-2.Rahavi E, et al. Updating the Dietary Guidelines for Americans: Status and Looking Ahead. Journal of the Academy of Nutrition and Dietetics 2015; 115, 2: 180-2.Al‐Daghri NM, et al. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. European journal of clinical investigation 2013; 43, 2: 183-9.Al‐Daghri NM, et al. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. European journal of clinical investigation 2013; 43, 2: 183-9.Amato MC, et al. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011; 10, 183: 1-8.Amato MC, et al. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011; 10, 183: 1-8.Mohammadreza B, et al. Prognostic significance of the complex “Visceral Adiposity Index” vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol 2012; 11: 20.Mohammadreza B, et al. Prognostic significance of the complex “Visceral Adiposity Index” vs. simple anthropometric measures: Tehran lipid and glucose study. Cardiovasc Diabetol 2012; 11: 20.Yang F, et al. Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness 2014.Yang F, et al. Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness 2014.Stenholm S, et al. Sarcopenic obesity-definition, etiology and consequences. Current opinion in clinical nutrition and metabolic care 2008; 11, 6: 693.Stenholm S, et al. Sarcopenic obesity-definition, etiology and consequences. Current opinion in clinical nutrition and metabolic care 2008; 11, 6: 693.Guo F, Garvey WT. Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes. The Journal of Clinical Endocrinology & Metabolism 2015; 100, 10: 3871-7.Guo F, Garvey WT. Development of a Weighted Cardiometabolic Disease Staging (CMDS) System for the Prediction of Future Diabetes. The Journal of Clinical Endocrinology & Metabolism 2015; 100, 10: 3871-7.Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity 2014; 22, 1: 110-8.Guo F, Moellering DR, Garvey WT. The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity 2014; 22, 1: 110-8.Mychka VB, Zhernakova YuV, Chazova IE. The recommendations of the experts of all-Russian scientific society of cardiology for the diagnosis and treatment of metabolic syndrome (second revision). Doctor. ru 2010; 3: 15-8. Russian (Мычка В. Б., Жернакова Ю. В., Чазова И. Е. Рекомендации экспертов всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома (второй пересмотр). Доктор. ру 2010; 3: 15-8).Mychka VB, Zhernakova YuV, Chazova IE. The recommendations of the experts of all-Russian scientific society of cardiology for the diagnosis and treatment of metabolic syndrome (second revision). Doctor. ru 2010; 3: 15-8. Russian (Мычка В. Б., Жернакова Ю. В., Чазова И. Е. Рекомендации экспертов всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома (второй пересмотр). Доктор. ру 2010; 3: 15-8).Alberti K, et al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120, 16: 1640-5.Alberti K, et al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120, 16: 1640-5.Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabetic medicine 2006; 23, 5: 469-80.Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabetic medicine 2006; 23, 5: 469-80.Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome—from insulin resistance to obesity and diabetes. Medical Clinics of North America 2011; 95, 5: 855-73.Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome—from insulin resistance to obesity and diabetes. Medical Clinics of North America 2011; 95, 5: 855-73.Grundy SM, et al. Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 2004; 109, 3: 433-8.Grundy SM, et al. Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 2004; 109, 3: 433-8.Junien C, Nathanielsz P. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes. Obesity Reviews 2007; 8, 6: 487-502.Junien C, Nathanielsz P. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes. Obesity Reviews 2007; 8, 6: 487-502.Kassi E, et al. Metabolic syndrome: definitions and controversies. BMC medicine 2011; 9, 1: 48.Kassi E, et al. Metabolic syndrome: definitions and controversies. BMC medicine 2011; 9, 1: 48.Lorenzo C, et al. The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes care 2007; 30, 1: 8-13.Lorenzo C, et al. The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes care 2007; 30, 1: 8-13.O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity reviews 2015; 16, 1: 1-12.O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity reviews 2015; 16, 1: 1-12.Prasad H, et al. Metabolic syndrome: definition and therapeutic implications. Postgraduate medicine 2012; 124, 1: 21-30.Prasad H, et al. Metabolic syndrome: definition and therapeutic implications. Postgraduate medicine 2012; 124, 1: 21-30.Benetos A, Thomas F, Pannier B, et al. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol 2008; 102:188-91.Benetos A, Thomas F, Pannier B, et al. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol 2008; 102:188-91.Nilsson PM, Engstrom G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in nondiabetic subjects: a population-based study comparing three different definitions. Diabet Med 2007; 24:464–472.Nilsson PM, Engstrom G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in nondiabetic subjects: a population-based study comparing three different definitions. Diabet Med 2007; 24:464–472.

The authors declare that there are no conflicts of interest present.